Universal Health Services (NYSE:UHS) Given New $166.00 Price Target at Robert W. Baird

Universal Health Services (NYSE:UHS) had its price objective decreased by stock analysts at Robert W. Baird from $204.00 to $166.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the health services provider’s stock. Robert W. Baird’s target price suggests a potential downside of 0.40% from the company’s previous close.

A number of other analysts have also recently weighed in on UHS. Stephens lowered their price objective on Universal Health Services from $235.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 29th. Barclays decreased their price target on Universal Health Services from $179.00 to $168.00 and set an “equal weight” rating for the company in a research note on Tuesday. Deutsche Bank Aktiengesellschaft cut their price target on shares of Universal Health Services from $261.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. TD Cowen lowered their price objective on shares of Universal Health Services from $230.00 to $197.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $194.00 target price on shares of Universal Health Services in a research report on Tuesday. Five investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat, Universal Health Services presently has a consensus rating of “Hold” and an average price target of $209.07.

Universal Health Services Price Performance

Shares of UHS stock opened at $166.67 on Wednesday. The stock’s 50-day moving average is $150.40 and its 200 day moving average is $178.81. Universal Health Services has a 1-year low of $140.08 and a 1-year high of $246.32. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.08 and a quick ratio of 1.01. The company has a market cap of $10.09 billion, a P/E ratio of 6.79, a PEG ratio of 0.85 and a beta of 1.07.

Universal Health Services (NYSE:UHS) last released its quarterly earnings results on Monday, July 27th. The health services provider reported $5.98 EPS for the quarter, beating the consensus estimate of $5.94 by $0.04. Universal Health Services had a net margin of 8.42% and a return on equity of 19.53%. The business had revenue of $4.64 billion during the quarter, compared to analyst estimates of $4.58 billion. During the same period in the prior year, the firm posted $5.35 earnings per share. The company’s quarterly revenue was up 8.3% on a year-over-year basis. Universal Health Services has set its FY 2026 guidance at 22.280-23.650 EPS. Research analysts predict that Universal Health Services will post 23.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Universal Health Services

Several hedge funds have recently bought and sold shares of the stock. Pzena Investment Management LLC grew its stake in shares of Universal Health Services by 31.5% during the 4th quarter. Pzena Investment Management LLC now owns 2,112,604 shares of the health services provider’s stock worth $460,590,000 after purchasing an additional 505,575 shares during the period. Dimensional Fund Advisors LP grew its holdings in Universal Health Services by 12.1% in the first quarter. Dimensional Fund Advisors LP now owns 1,781,262 shares of the health services provider’s stock valued at $318,812,000 after purchasing an additional 192,351 shares during the period. Arrowstreet Capital Limited Partnership increased its position in shares of Universal Health Services by 1.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,226,577 shares of the health services provider’s stock valued at $219,520,000 after buying an additional 20,577 shares in the last quarter. Norges Bank purchased a new stake in shares of Universal Health Services in the fourth quarter valued at approximately $199,334,000. Finally, Morgan Stanley raised its stake in shares of Universal Health Services by 59.5% during the 4th quarter. Morgan Stanley now owns 871,377 shares of the health services provider’s stock worth $189,978,000 after buying an additional 325,162 shares during the period. Hedge funds and other institutional investors own 86.05% of the company’s stock.

Universal Health Services News Summary

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: UHS reported second-quarter adjusted earnings of $5.98 per share, ahead of the approximately $5.94 consensus estimate, while revenue rose 8.3% year over year to $4.64 billion, exceeding expectations of $4.58 billion. Growth in both acute-care and behavioral-health operations supported the results. UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
• Positive Sentiment: Management forecast 2026 adjusted EBITDA less noncontrolling interests of $2.61 billion to $2.72 billion and said it expects to remain “highly active” with share repurchases. Buybacks could provide support for per-share earnings and the stock valuation. UHS 2026 EBITDA Forecast and Buybacks
• Positive Sentiment: UHS views its Talkspace investment as an accelerator for outpatient growth, potentially expanding its behavioral-health access and digitally enabled care offerings. Why UHS Sees Talkspace as an Accelerant for Outpatient Growth
• Neutral Sentiment: Cantor Fitzgerald reaffirmed its “neutral” rating but set a $194 price target, while Barclays maintained “equal weight” and reduced its target to $168. The mixed analyst view suggests upside potential but continued caution.
• Negative Sentiment: UHS reduced its 2026 EPS guidance to $22.28-$23.65, below the roughly $23.44 analyst consensus midpoint, citing uncertainty surrounding Medicaid supplemental-payment programs. Higher labor and operating costs also remain a pressure on margins, tempering the positive earnings surprise. UHS Cuts 2026 Forecast on Medicaid Reimbursement Uncertainty

Universal Health Services Company Profile

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.